KRAS and familial pancreatic carcinoma: Multiple approaches have been used to identify the malignant activity of the K-Ras G12V mutation in various cancers such as colorectal cancer, lung cancer, and pancreatic cancer in patients and animal models [12,13,14,15,16,17,18,19].